vix.ing · top · new · best · stats · spec

Jeffrey E. Lancet

  1. Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML
    2014/04/01 by Jeffrey E. Lancet, Jorge E. Cortes, Jörge E. Cortes +13 · 26 citations
    Medicine · Biochemistry, Genetics and Molecular Biology · #Acute Myeloid Leukemia Research #Histone Deacetylase Inhibitors Research #Advanced biosensing and bioanalysis techniques